CLARKE, Andrew John,BABIDGE, Catherine Mary,NI, Jiayi
申请号：
CL2019000840
公开号：
CL2019000840A1
申请日:
2019.03.28
申请国别(地区):
CL
年份:
2019
代理人:
摘要：
(b) Improve the balance of beneficial intestinal microorganisms in animals by providing a component and an amp； Oacute； N contains beta-case amp； IACUTE； NA, which contains at least 75% of the weight percentage of beta-case amp； IACUTE； NA is a variant of beta-case amp； IACUTE； NA, which contains acrylonitrile-acrylonitrile-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor-neighbor Neighbor-Neighbor-Neighbor-Neighbor-Neighbor-Neighbor-Neighbor-Neighbor- Posici AMP； OACUTE； N 67 de Amino Beta-case AMP； IACUTE； NA sequence AMP； AACUTE； DITO LT； / P GT；<；p>；MEJORAR EL EQUILIBRIO DE LA MICROBIOTA INTESTINAL BENEFICIOSA DE UN ANIMAL, PROPORCIONANDO UNA COMPOSICIÓ；N QUE CONTIENE BETA-CASEÍ；NA, EN LA QUE AL MENOS EL 75% EN PESO DE LA BETA-CASEÍ；NA ES UNA VARIANTE DE BETA-CASEÍ；NA QUE TIENE UNA PROLINA EN LA POSICIÓ；N 67 DE LA AMINO BETA-CASEÍ；NA SECUENCIA DE Á；CIDO.<；/p>；
